Drugs / ChAd3-hliNSmut
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03688061 | Dec 2017 → Aug 2019 | hepatitis C virus infection | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAd3-hliNSmut | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03688061 ↗ |
| Modality | Vaccine | “Attenuated chimpanzee adenovirus (ChAd) vectored vaccine against HCV” NCT03688061 ↗ |
| Route | Intramuscular | “IM at week 0” NCT03688061 ↗ |